Hydroxychloroquine (HCQ) Treatment for Hospitalized Patients with COVID- 19.
Infectious disorders drug targets(2022)
摘要
Patients treated with HCQ demonstrated a significant benefit in the primary endpoints in our study, namely, transfer to the intensive care unit, need for mechanical ventilation, and in-hospital death. HCQ improves prognosis in hospitalized patients with COVID-19.
更多查看译文
关键词
COVID- 19 treatment,acute respiratory syndrome,an antimalarial drug,heart and brain,hydroxychloroquine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要